SuperworthXerox XRX
- Market cap
- $336.2M
- PE
- n/m
- a loss over the last year
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 0.0×
- EV/EBIT
- n/m
- a sliver of operating profit
- Revenue, 12 months
- $7.8B
- +26% on a year ago
- Net margin
- −11.9%
- Free cash flow yield
- 35.1%
Xerox trades at 0.0× sales. Its trailing earnings are negative, so it has no PE. Revenue was $7.8B over the last twelve months, up 26% on a year earlier with a −12% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.7B−6% | $1.8B−9% | $1.5B−12% | $1.6B−10% | $1.5B−8% | $1.6B−9% | $1.5B−3% | $1.6B−0% | $2B+28% | $2B+26% | $1.8B+27% | $1.9B+22% | |
| Cost of revenue | $1.1B−7% | $1.1B−8% | $1.1B−3% | $1.1B−6% | $1B−5% | $1.1B−3% | $1B−3% | $1.1B+6% | $1.5B+47% | $1.4B+30% | $1.3B+26% | $1.2B+10% |
| Gross profit | $566M−3% | $622M−12% | $443M−29% | $520M−18% | $495M−13% | $502M−19% | $426M−4% | $451M−13% | $445M−10% | $579M+15% | $549M+29% | $688M+53% |
| R&D | $52M−29% | $56M−19% | $49M−23% | $50M−12% | $45M−14% | $47M−16% | $42M−14% | $43M−14% | $74M+64% | $71M+51% | $64M+52% | $67M+56% |
| SG&A | $416M−1% | $440M+3% | $397M−3% | $393M−9% | $370M−11% | $377M−14% | $378M−5% | $368M−6% | $477M+29% | $431M+14% | $430M+14% | $432M+17% |
| $76M | −$16M | −$106M | $58M−46% | −$1B | $34M | $1M | $20M−66% | −$195M−81% | $46M+35% | −$20M | $136M+580% | |
| Interest expense | $44M−10% | $58M+21% | $53M+6% | $60M+30% | $57M+30% | $55M−5% | $33M−38% | $55M−8% | $101M+77% | $100M+82% | $84M+155% | $100M+82% |
| Pre-tax income | $64M | −$88M | −$150M | $25M | −$1.1B | −$4M−96% | −$67M−55% | −$60M | −$300M−72% | −$61M+1425% | −$73M+9% | $31M |
| $15M+400% | −$30M | −$37M | $7M | $118M+687% | $17M | $23M | $46M+557% | $460M+290% | $12M−29% | $32M+39% | $18M−61% | |
| Net income | $49M | −$58M | −$113M | $18M | −$1.2B | −$21M−64% | −$90M−20% | −$106M | −$760M−37% | −$73M+248% | −$105M+17% | $13M |
| $0.28 | −$0.48 | −$0.94 | $0.11 | −$9.71 | −$0.19−60% | −$0.75−20% | −$0.87 | −$6.01−38% | −$0.59+211% | −$0.84+12% | $0.07 | |
| 157.1M+2% | 126M | 123.9M−21% | 124.2M−21% | 124.3M−21% | 124.4M−1% | 125.2M+1% | 125.8M+1% | 126.9M+2% | 127.9M+3% | 129M+3% | 130.9M+4% |
Revenue: Q1 FY18: 6 months less the 3 months printed beside them.
Cost of revenue: Q1 FY18: 6 months less the 3 months printed beside them.
Gross profit: Q1 FY18: 6 months less the 3 months printed beside them. 33 periods, Q2 FY18 to Q2 FY26: not printed by the filing, worked out from its own lines.
R&D: Q1 FY18 and Q1 FY19: 6 months less the 3 months printed beside them.
SG&A: Q1 FY18: 6 months less the 3 months printed beside them.
Operating income: Q1 FY18: 6 months less the 3 months printed beside them. 33 periods, Q2 FY18 to Q2 FY26: not printed by the filing, worked out from its own lines.
Interest expense: Q1 FY18: 6 months less the 3 months printed beside them.
Pre-tax income: Q1 FY18: 6 months less the 3 months printed beside them.
Income tax: Q1 FY18: 6 months less the 3 months printed beside them.
Net income: Q1 FY18 and Q1 FY19: 6 months less the 3 months printed beside them.
EPS, diluted: 4 periods, Q1 FY19 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: Q1 FY19: share-days: the 6-month average less the second quarter's. 13 periods, Q2 FY19 to Q2 FY26: not printed by the filing, worked out from its own lines. Q4 FY23: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Computer Hardware nearest Xerox's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| XRXXerox | $336.2M | n/m | n/a | 0.0× | +26% | −11.9% | |
| IMMRImmersion | $236.4M | 21.6× | 7.4× | 0.1× | +4% | 0.6% | |
| OSSOne Stop Systems | $147.4M | 118× | 57.5× | n/m | n/m | n/m | |
| MITKMitek Systems | $841.1M | 39.7× | 69.9× | 4.3× | +11% | 11.4% | |
| VYXNCR Voyix | $1.2B | 21.0× | 18.5× | 0.5× | −5% | 3.0% | |
| CRSRCorsair Gaming | $1.5B | 44.3× | 21.3× | 1.0× | +3% | 2.5% | |
| OMCLOmnicell | $1.7B | 44.9× | 74.0× | 1.4× | +8% | 3.1% | |
| DBDDIEBOLD NIXDORF | $2.3B | 22.6× | 28.9× | 0.6× | +5% | 2.9% | |
| PBIPitney Bowes | $2.4B | 14.2× | 15.2× | 1.3× | −5% | 10.0% | |
| Peer median | $1.3B | 31.1× | 25.1× | 1.0× | +4% | 3.0% |
More on Xerox
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #3of 533Technology stocks with the lowest price to sales ratio
- #2of 345Technology stocks with the highest free cash flow yield
- #1of 28Computer hardware stocks with the lowest price to sales ratio
- #1of 17Computer hardware stocks with the highest free cash flow yield
- #10of 24Computer hardware stocks with the fastest revenue growth
Its groups
About
- Industry
- Computer Hardware
- Sector
- Technology
Valuation data, not investment advice. Prices as of .